Long-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with Viscum album L. Extract: A Case Report

Simple item page
dc.contributor.authorReynel, María
dc.contributor.authorVillegas, Yván
dc.contributor.authorWerthmann, Paul G.
dc.contributor.authorKiene, Helmut
dc.contributor.authorKienle, Gunver S.
dc.date.accessioned2024-05-23T18:54:18Z
dc.date.available2024-05-23T18:54:18Z
dc.date.digitized2021-03-14 20:37:25
dc.date.issued2021
dc.description.abstract<p><strong>Abstract</strong></p> <p>Retroperitoneal sarcomas are rare. Dedifferentiated liposarcomas (DDLs) are high-grade tumors with a high propensity for local recurrence and metastasis and are associated with reduced survival. Radical resection remains the standard treatment of sarcomas. Meanwhile, Viscum album L. extract (VAE) is used in cancer patients owing to its cytostatic and immunomodulating effects and to its ability to improve patients’ quality of life. Case Presentation: A 68-year-old male patient underwent a resection of a DDL (T2 N0 M0, FNCLCC grade 2, stage IIIA) in the retroperitoneum. Three months after this first surgery, a recurrence occurred, and was treated with neoadjuvant and adjuvant doxorubicin plus ifosfamide and surgery (resection). A second recurrence—11 months after the second surgery—was treated with surgery and radiotherapy. The patient then began to undergo VAE treatment (0.2 mg-2 mg, subcutaneously, thrice a week). After the VAE treatment was initiated, the patient reported improved quality of life. A third recurrence—12 months after the third surgery—was treated with surgery, radiotherapy, and with an increased dose of VAE (20 mg). Sixty-nine months (5.8 years) after the fourth surgery a fourth recurrence occurred. It was again treated with surgery, along with a month of intravenous VAE infusions and subsequent subcutaneous VAE (20 mg) treatment. Finally, a fifth recurrence—5 months after the fifth surgery—was treated with subcutaneous and intravenous VAE applications and eribulin. The patient died 11 months after the last recurrence; he received a total of 103 months (8.6 years) of VAE treatment and achieved 10.5 years of survival. Conclusion: The case presented herein shows a long-time survival and a prolonged recurrence-free interval in a patient with retroperitoneal DDL treated with surgery, chemotherapy, radiotherapy, and VAE injections. On the basis of the antitumoral and immunomodulating effects of VAE and on the reported prolonged survival of VAE-treated patients with other types of tumors, the adjunct VAE treatment is presumed to have contributed to the favorable outcome. Regarding the clinical relevance of VAE treatment, further investigations are needed.</p> <p><strong>Keywords</strong>: retroperitoneal liposarcoma, dedifferentiated liposarcoma, Viscum album, recurrence, survival</p> <p><strong>Citation</strong>: Reynel, M., Villegas, Y., Werthmann, P. G., Kiene, H., &amp; Kienle, G. S. (2021). Long-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with Viscum album L. Extract: A Case Report. <em>Integrative Cancer Therapies</em>, <em>20</em>, 1534735421995258. <a href="https://doi.org/10.1177/1534735421995258" target="_blank">https://doi.org/10.1177/1534735421995258</a></p>
dc.description.notesfixed
dc.identifier.citationReynel, M., Villegas, Y., Werthmann, P. G., Kiene, H., & Kienle, G. S. (2021). Long-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with Viscum album L. Extract: A Case Report. Integrative Cancer Therapies, 20, 1534735421995258. https://doi.org/10.1177/1534735421995258
dc.identifier.doihttps://doi.org/10.1177/1534735421995258
dc.identifier.externalUrl/library/2021/3/8/long-term-survival-of-a-patient-with-recurrent-dedifferentiated-high-grade-liposarcoma-of-the-retroperitoneum-under-adjuvant-treatment-with-viscum-album-l-extract-a-case-report
dc.identifier.urihttps://hdl.handle.net/20.500.14430/434
dc.subject.otherretroperitoneal liposarcoma
dc.subject.otherdedifferentiated liposarcoma
dc.subject.otherViscum album
dc.subject.otherrecurrence
dc.subject.othersurvival
dc.subject.otherCancer
dc.titleLong-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with Viscum album L. Extract: A Case Report
dspace.entity.typePublication
oaire.citation.titleIntegr Cancer Ther
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Reynel_Long-term survival of a patient with recurrent dedifferentiated_2021.pdf
Size:
442.94 KB
Format:
Adobe Portable Document Format
Download
Collections
01 Anthroposophic medicine (AM), therapies and health
02 Case studies in cancer